Works in Alimentary Pharmacology & Therapeutics, 2022, Vol 55, Issue 12


Results: 13
    1
    2

    The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double‐blind multicentre study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1524, doi. 10.1111/apt.16959
    By:
    • Chen, Songfeng;
    • Liu, Deliang;
    • Chen, Honghui;
    • Liao, Aijun;
    • Li, Fangfang;
    • Liu, Chengxia;
    • Li, Xing;
    • Li, Shengbao;
    • Zhang, Yan;
    • Wang, Yang;
    • Xia, Min;
    • Guo, Qinghong;
    • Miao, Xinpu;
    • Wen, Zhili;
    • Xu, Min;
    • Yin, Hekun;
    • Chen, Huixin;
    • Chen, Minhu;
    • Xiao, Yinglian
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Lower effectiveness of intravenous steroid treatment for moderate‐to‐severe ulcerative colitis in hospitalised patients with older onset: a multicentre cohort study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1569, doi. 10.1111/apt.16865
    By:
    • Okabayashi, Shinji;
    • Yamazaki, Hajime;
    • Tominaga, Keiichi;
    • Miura, Miki;
    • Sagami, Shintaro;
    • Matsuoka, Katsuyoshi;
    • Yamaguchi, Yoshiharu;
    • Noake, Toshihiro;
    • Ozeki, Keiji;
    • Miyazaki, Ryosuke;
    • Kamano, Toshiaki;
    • Fukuda, Tomohiro;
    • Yoshioka, Kyoko;
    • Ando, Katsuyoshi;
    • Fukuzawa, Masakatsu;
    • Andoh, Akira;
    • Yamamoto, Yosuke;
    • Hibi, Toshifumi;
    • Kobayashi, Taku
    Publication type:
    Article
    10
    11
    12
    13

    Issue Information.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1475, doi. 10.1111/apt.16422
    Publication type:
    Article